- Home
- IRMD
IRMD
iRadimed Corporation
as 12-17-2024 3:32pm EST
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | WINTER SPRINGS |
| Market Cap: | 618.5M | IPO Year: | 2014 |
| Target Price: | $60.00 | AVG Volume (30 days): | 43.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.46 | EPS Growth: | 13.16 |
| 52 Week Low/High: | $40.18 - $57.95 | Next Earning Date: | 02-06-2025 |
| Revenue: | $71,305,130 | Revenue Growth: | 13.23% |
| Revenue Growth (this year): | 13.29% | Revenue Growth (next year): | 10.76% |
Stock Insider Trading Activity of iRadimed Corporation (IRMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GLENN JOHN | IRMD | CHIEF FINANCIAL OFFICER | Dec 2 '24 | Sell | $54.18 | 2,500 | $135,449.25 | 4,383 | |
| VUOTO ANTHONY | IRMD | Director | Nov 6 '24 | Sell | $55.99 | 2,690 | $150,616.06 | 14,234 |
Latest iRadimed Corporation News
IRMD Breaking Stock News: Dive into IRMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Should You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43?
GlobeNewswire
8 days ago
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
Simply Wall St.
19 days ago
Three Undiscovered Gems in the US Market to Enhance Your Portfolio
Simply Wall St.
22 days ago
Is There An Opportunity With IRADIMED CORPORATION's (NASDAQ:IRMD) 47% Undervaluation?
Simply Wall St.
a month ago
IRADIMED CORPORATION (NASDAQ:IRMD) Passed Our Checks, And It's About To Pay A US$0.15 Dividend
GlobeNewswire
a month ago
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
Simply Wall St.
a month ago
Results: IRADIMED CORPORATION Exceeded Expectations And The Consensus Has Updated Its Estimates
GuruFocus.com
2 months ago
iRadimed Corp (IRMD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Shifts
Compare IRMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRMD iRadimed Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.